ArticleInvestigational new drugs2020

Safety and clinical activity of the Notch inhibitor, crenigacestat (LY3039478), in an open-label phase I trial expansion cohort of advanced or metastatic adenoid cystic carcinoma.

C Even et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.